APPROPRIATE PATIENT

APPROPRIATE PATIENT. Means a patient selected for a therapy, that is either (a) indicated for chronic intravascular infusion of floxuridine (FUDR) for the treatment primary of metastatic cancer or (b) indicated for malignant intractable pain in patients with lung-, breast-, prostate- or colorectal-cancer. Those patients must have completed HAI Evaluation or must have completed an intrathecal morphine screening trial, respectively. 1